All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
EquityEquity - Follow-ons and Rights issues

SkyePharma seeks new capital for bond buyback

SkyePharma, the UK pharmaceutical company, is set to restructure its balance sheet with a big share issuance to be used to retire debt.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree